Oragenics (LTS:0A64) Short-Term Capital Lease Obligation : $0.00 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Oragenics Short-Term Capital Lease Obligation?

Oragenics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.00 Mil.

Oragenics's annual Short-Term Capital Lease Obligation declined from Dec. 2022 ($0.20 Mil) to Dec. 2023 ($0.01 Mil) and declined from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.00 Mil).

Oragenics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Oragenics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oragenics Short-Term Capital Lease Obligation Chart

Oragenics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.18

0.19

0.20

0.01

Oragenics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Oragenics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Oragenics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Oragenics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Oragenics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oragenics Inc (LTS:0A64) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

OGEN:USA

Address

1990 Main Street, Suite 750, Sarasota, FL, USA, 34236

Website

https://www.oragenics.com

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Oragenics Headlines

No Headlines